Actor Josh Duhamel, 53, has publicly endorsed testosterone replacement therapy (TRT) after discovering low levels in his early 40s. He co-founded Gatlan, a men's health company, despite warnings from former representatives that the venture could damage his image. Duhamel reports feeling stronger and more energetic, injecting testosterone three times weekly. Experts caution that TRT is for medical deficiency, not performance enhancement, and carries risks including infertility and blood clots.
Actor Josh Duhamel, 53, stated on the 'Human Upgrade' podcast that testosterone replacement therapy (TRT) has improved his physical health and energy levels, allowing him to feel better than he did in his 30s. Duhamel began TRT approximately five years ago after discovering low testosterone levels in his early 40s. He co-founded Gatlan, a men's health company offering hormone optimization and longevity treatments, despite warnings from former representatives that the venture could harm his public image. Duhamel injects testosterone three times weekly to maintain consistent levels, citing benefits for joint pain, back strength, and overall vitality. He emphasized that the therapy helps him keep up with his three young children, including a 3-month-old daughter and a 2.5-year-old son. Duhamel advocates for broader public discussion on hormone optimization, noting that medical science supports these treatments for longevity and quality of life. The FDA has approved testosterone products for men with low testosterone associated with specific medical conditions, though it requires warnings regarding potential increased blood pressure.
